Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1957 1
1958 2
1959 3
1961 1
1962 4
1963 9
1964 12
1965 6
1966 3
1967 7
1968 12
1969 8
1970 8
1971 10
1972 10
1973 14
1974 8
1975 17
1976 6
1977 10
1978 7
1979 7
1980 12
1981 7
1982 12
1983 9
1984 15
1985 9
1986 4
1987 7
1988 15
1989 10
1990 10
1991 7
1992 8
1993 16
1994 9
1995 2
1996 8
1997 3
1998 11
1999 11
2000 7
2001 9
2002 6
2003 10
2004 20
2005 13
2006 7
2007 15
2008 15
2009 16
2010 18
2011 15
2012 18
2013 21
2014 33
2015 20
2016 14
2017 28
2018 24
2019 20
2020 26
2021 38
2022 31
2023 27
2024 35
2025 47
2026 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

861 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced immune hemolytic anemia.
Garratty G. Garratty G. Hematology Am Soc Hematol Educ Program. 2009:73-9. doi: 10.1182/asheducation-2009.1.73. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008184 Review.
Drug-induced immune hemolytic anemia (DIIHA) is rare, and a specialized laboratory is often required to provide the optimal serological tests to confirm the diagnosis. ...In these latter cases, the drug affects the immune system, causing production of …
Drug-induced immune hemolytic anemia (DIIHA) is rare, and a specialized laboratory is often required to provide …
Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a nationwide cohort study.
Maquet J, Lafaurie M, Michel M, Lapeyre-Mestre M, Moulis G. Maquet J, et al. Blood Adv. 2024 Feb 13;8(3):817-826. doi: 10.1182/bloodadvances.2023009801. Blood Adv. 2024. PMID: 37782770 Free PMC article.
More than 130 drugs have been suspected to induce immune hemolytic anemia. Comparative studies measuring the risk of drug-induced immune hemolytic anemia (DIIHA) are lacking. ...We identified an association between immune hemolytic …
More than 130 drugs have been suspected to induce immune hemolytic anemia. Comparative studies measuring the risk of drug …
Drug-induced hemolytic anemia: Pharmacological aspects.
Renard D, Rosselet A. Renard D, et al. Transfus Clin Biol. 2017 Sep;24(3):110-114. doi: 10.1016/j.tracli.2017.05.013. Epub 2017 Jun 23. Transfus Clin Biol. 2017. PMID: 28648734 Review.
Drug-induced hemolytic anemia is a very rare but potentially lethal adverse drug reaction, which can take the form of oxidative damage to vulnerable erythrocytes (as in glucose-6-phosphate dehydrogenase deficiency), drug-induced thromboti …
Drug-induced hemolytic anemia is a very rare but potentially lethal adverse drug reaction, which can take the fo …
Drug-induced immune hemolytic anemia.
Garratty G, Petz LD. Garratty G, et al. Am J Med. 1975 Mar;58(3):398-407. doi: 10.1016/0002-9343(75)90606-3. Am J Med. 1975. PMID: 1090160 Review.
Drug administration causes from 16 to 18 per cent of cases of acquired immune hemolytic anemia. The pathogenesis of erythrocyte sensitization by drug-related antibody with or without fixation of complement is variable, and there is a relationship between the respons …
Drug administration causes from 16 to 18 per cent of cases of acquired immune hemolytic anemia. The pathogenesis of erythrocyt …
Drug-induced hemolytic anemia.
Beutler E. Beutler E. Pharmacol Rev. 1969 Mar;21(1):73-103. Pharmacol Rev. 1969. PMID: 4887725 Review. No abstract available.
Cefoperazone/sulbactam-induced hemolytic anemia.
Sun XM, Liu LH, Wu Q, Wang HG. Sun XM, et al. J Postgrad Med. 2023 Jan-Mar;69(1):46-49. doi: 10.4103/jpgm.JPGM_1335_20. J Postgrad Med. 2023. PMID: 34528516 Free PMC article.
Drug-induced hemolytic anemia (DIHA) is a rare complication of drug therapy and usually underdiagnosed. ...After cefoperazone/sulbactam was given as anti-infection treatment, the patient developed hemolytic anemia on the third day. Cefope …
Drug-induced hemolytic anemia (DIHA) is a rare complication of drug therapy and usually underdiagnosed. ...After …
How I treat warm autoimmune hemolytic anemia.
Barcellini W, Fattizzo B. Barcellini W, et al. Blood. 2021 Mar 11;137(10):1283-1294. doi: 10.1182/blood.2019003808. Blood. 2021. PMID: 33512406 Free article. Review.
Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by immunoglobulin G (IgG) autoantibodies, with or without complement activation. ...The different pathogenic mechanisms, their complex interplay, and changes over time may explai …
Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by immunoglobulin G (IgG) autoantibodi …
Vancomycin-Induced Hemolytic Anemia.
Siddiqui F, Cheema A, Kamran A. Siddiqui F, et al. Cureus. 2023 May 18;15(5):e39191. doi: 10.7759/cureus.39191. eCollection 2023 May. Cureus. 2023. PMID: 37216133 Free PMC article.
Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-mediated mechanism. ...Hematological parameters improved after the discontinuation of vancomycin. Mechanism and management of drug-indu …
Drug-induced hemolytic anemia is rare and can occur either by an immune-mediated mechanism or a non-immune-media …
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
Loriamini M, Cserti-Gazdewich C, Branch DR. Loriamini M, et al. Int J Mol Sci. 2024 Apr 12;25(8):4296. doi: 10.3390/ijms25084296. Int J Mol Sci. 2024. PMID: 38673882 Free PMC article. Review.
Autoimmune hemolytic anemias (AIHAs) are conditions involving the production of antibodies against one's own red blood cells (RBCs). ...Although usually self-remitting, management may consider monoclonal antibodies to C1q or C5. (5) Direct antiglobulin test-negative AIHA ( …
Autoimmune hemolytic anemias (AIHAs) are conditions involving the production of antibodies against one's own red blood cells (RBCs). …
Drug-induced immune hemolytic anemia.
Salama A. Salama A. Expert Opin Drug Saf. 2009 Jan;8(1):73-9. doi: 10.1517/14740330802577351. Expert Opin Drug Saf. 2009. PMID: 19236219 Review.
BACKGROUND: Drug-induced immune hemolytic anemia is frequently associated with serious complications. OBJECTIVE: To identify which drugs are implicated in drug-induced immune hemolytic anemia, how they stimulate the producti …
BACKGROUND: Drug-induced immune hemolytic anemia is frequently associated with serious complications. OBJECTIVE: …
861 results